Actinium Pharmaceuticals Inc
ATNM
|
|
| |
|
| Trading Volume | 7,028 |
|
|
6.93 - 1.82 |
| Market Cap Full | $ 52.4M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 14% | - | - | -16.4% |
| Q2 | - | 55.4% | - | -5.9% |
| Q3 | - | -72.4% | - | 53.4% |
| Q4 | - | -35.6% | - | 45.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | -72.4 | - | - | - | -13.5 |
| 2023 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2022 | |||||||||||
| -11.5 | 0.1 | -5.6 | 17 | -7.7 | -12.9 | 2.5 | 42.6 | 5 | 83.5 | -18.2 | -2.7 |
| 2021 | |||||||||||
| -1.1 | 3.2 | -6.3 | 0.5 | 5.6 | -2.2 | -15.8 | -8.7 | 45.7 | -11.3 | -8.8 | -14.8 |
| 2020 | |||||||||||
| 12.3 | -10.5 | -12.2 | -4.9 | 15.3 | 65.3 | 63.9 | 1328.8 | 17.7 | 2.8 | 10.4 | -27.6 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.4 | -0.2 | -0.3 | -0.9 |
| Q2 | -0.6 | -0.3 | -0.3 | -0.4 |
| Q3 | -0.5 | -0.4 | -0.3 | -0.4 |
| Q4 | 0 | -0.4 | -0.4 | -0.1 |
| A | -1.5 | -1.4 | -1.2 | -1.8 |